Posted by Hugh on June 7, 2019, at 18:45:22
In reply to Re: SAGE-217 » Hugh, posted by beckett2 on June 6, 2019, at 23:16:50
Sage-217 is the pill version of brexanolone. The IV version of this drug, Zulresso, was approved by the FDA a few months ago. It's the first drug ever approved for postpartum depression. One of its advantages is that it starts to work within days, not weeks. There are also clinical trials underway for Sage-217 and major depressive disorder, insomnia, and bipolar depression.
poster:Hugh
thread:1104754
URL: http://www.dr-bob.org/babble/20190513/msgs/1104776.html